![Mark A. Gohr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Gohr
Directeur Financier/CFO chez ANTH1, Inc.
Postes actifs de Mark A. Gohr
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Comptroller/Controller/Auditor | 17/06/2010 | - |
Directeur Financier/CFO | 17/06/2010 | - | |
Directeur/Membre du Conseil | 17/07/2008 | 17/06/2010 |
Historique de carrière de Mark A. Gohr
Formation de Mark A. Gohr
The University of Colorado | Graduate Degree |
Hastings College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
- Bourse
- Insiders
- Mark A. Gohr
- Expérience